Synchron
Brooklyn, NY
- Brain-computer interfaces
- Neurorehabilitation and assistive tech
- Series E
Synchron develops implantable brain-computer interfaces designed to help people with motor impairment control digital devices using their thoughts. Its Stentrode BCI is delivered by catheter into a brain blood vessel, avoiding open brain surgery in the clinical-trial procedure.
- Open roles
- 10
- Posted last 30 daysPosted in the last 30 days
- 5
- TrialsClinical trials
- 4
- RaisedTotal raised
- $590M
- Jun 2026Latest priced round, Jun 2026
- Series E
reccy insights
Synchron’s recent milestones span financing, product integration, and organizational expansion. On Jun 29, 2026, it raised $275 million in a Series E led by General Atlantic, bringing the total of identified round amounts to $590 million. In June 2026, coverage described the company as targeting a pivotal trial for its brain-computer interface; that target should not be mistaken for confirmation that the trial has begun. Earlier, on Nov 6, 2025, Synchron announced a $200 million Series D and established an engineering hub in San Diego to support next-generation BCI development. The company also expanded its leadership team on Aug 19, 2025, appointing Andy Rasdal Chief of Staff and Mark Brister Vice President of Research and Development. Product milestones included a Aug 4, 2025 demonstration of a user controlling an iPad through the implant and a 2025 announcement of native integration plans for Apple devices. In March 2025, Synchron and NVIDIA introduced work on Chiral, a cognitive AI model using neural data and NVIDIA Holoscan. No awards are identified in the available company information.
Written by reccy's AI from company sites, press and funding records · updated Nov 2026
Open roles10
5 roles posted in the last 30 days
Open roles by the month Synchron posted them
- 11Jun
- 11Jul
- 00Aug
- 11Sep
- 66Oct
- 11Nov
Engineering and quality roles in San Diego, California.
No current openings listed on the official careers page.
- Posted 3d ago
Principal R&D Engineer, RF & Impant Power
San Diego, CA · Principal · Posted 3d ago
- Posted 10d ago
Catheter Engineering Technician
San Diego, CA · Mid · Posted 10d ago
- Posted 16d ago
Senior R&D Engineer, Electrical & FPGA Design
San Diego, CA · Senior · Posted 16d ago
- Posted 18d ago
Senior Technical Recruiter
San Diego, CA · Senior · Posted 18d ago
- Posted 29d ago
Principal Mechanical Engineer
San Diego, CA · Principal · Posted 29d ago
What makes Synchron distinct
- 01Uses a catheter-delivered approach to place its BCI in a brain blood vessel, without open brain surgery in the clinical-trial procedure.
- 02Builds technology around restoring, extending, and protecting human agency.
- 03Aims to develop motor models for people with motor impairment and cognition models for people with cognitive decline.
- 04Combines implantable hardware development in San Diego with neural data and cognition research in New York City.
Technology & products2
- Synchron Brain-Computer Interface (BCI)
A minimally invasive brain-computer interface device that enables users to control digital devices using their thoughts.
- Chiral™ Cognitive AI Brain Foundation Model
A cognitive AI brain foundation model developed to enhance neurotechnology applications addressing human body limitations.
- Stentrode implantable brain-computer interface
- Catheter-deployed neural recording and wireless implant telemetry
- Smartphone and tablet app for controlling digital devices through brain signals
- Real-time neural data pipelines and closed-loop neurofeedback
- Neural signal models for cognition
Clinical trials4
- Functional Outcomes and Control Using Synchron BCI - AustraliaActive, not recruitingNCT07533903 · 10 participants · started May 2026
- Neurologic Disorder
- Neurologic Diseases
- MND (Motor Neurone DIsease)
- Motor Neuron Disease
- INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility StudyActive, not recruitingNCT07543367 · 10 participants · started May 2026
- Neurological Disorder
- ALS (Amyotrophic Lateral Sclerosis)
- Motor Neuron Disease
- ALS - Amyotrophic Lateral Sclerosis
Recent updates16
- Apr 27, 2026Award
The 10 Most Influential New Frontiers Companies of 2026
time.com - Mar 27, 2026Award
The most innovative data science companies of 2026
fastcompany.com - Dec 31, 2025Product launch
Synchron announced plans for native integration with Apple’s BCI Human Interface Device protocol, enabling users with its implant to control iPhone, iPad, and Apple Vision Pro with their thoughts. The announcement described a planned rollout of compatible features to trial participants.
biospace.com
In the Cortex
- From Synchron to Australian Ultra BionicsForbes Australia · Oct 20, 2026
- Synchron Moves BCI Toward Clinical TranslationArticles | Neurofounders · Apr 18, 2026
- What It’s Like to Have a Brain Implant for 5 Yearswired.com · Mar 4, 2026
Funding
- Series EJun 2026$275MLed by General Atlantic
- Series DNov 2025$200MLed by Double Point Ventures
- Series CDec 2022$75MLed by ARCH Venture Partners
Similar companies
About Synchron
- Products
- Synchron Brain-Computer Interface (BCI), Chiral™ Cognitive AI Brain Foundation Model
- Leadership
- Nicholas Opie, CTO & FounderThomas Oxley, CEO & FounderMark Brister, Vice President of Research and DevelopmentRiki Banerjee, Chief Technology Officer
- Focus areas
- Emerging_unicorn
- Headquarters
- Brooklyn, NY
- Employees
- 101–250